Manufacturer of precision medicine for diagnostic and drug development applications
InnoSIGN has raised €7.3M across 1 funding round from 4 investors, most recently a Series A round in Apr 2022. Based in Eindhoven, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-06 | Series A | €7.3M |
| Brabant Development Agency,Casdin Capital,Life Science Angels,Thuja Capital |
| View deal → |
